Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,267 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC

NCT00000999

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • LaJolla Veterans Administration Med Ctr La Jolla, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC

NCT00000753

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • USC CRS Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • St. Louis ConnectCare, Infectious Diseases Clinic St Louis, Missouri, United States
  • Washington U CRS St Louis, Missouri, United States
View Trial Details
Completed

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

NCT00000848

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +20 more
Locations
  • Stanford CRS Palo Alto, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
View all 16 locations
View Trial Details
Completed

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

NCT00000892

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Willow Clinic Menlo Park, California, United States
View all 45 locations
View Trial Details
Completed

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

NCT00000771

Conditions
Acquired Immunodeficiency Syndrome, Animal Diseases, Blood-Borne Infections, +24 more
Locations
  • USC CRS Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

NCT00001043

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

NCT00000774

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • San Francisco Gen. Hosp. San Francisco, California, United States
View all 37 locations
View Trial Details
Completed

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

NCT00001042

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details

Related conditions